SANOFI AVENTIS US FDA Approval NDA 202992

NDA 202992

SANOFI AVENTIS US

FDA Drug Application

Application #202992

Documents

Letter2012-09-14
Letter2016-06-06
Label2012-09-14
Label2014-10-21
Review2012-11-05
Letter2014-10-22
Label2016-06-06
Summary Review2012-11-05
Letter2016-12-01
Label2016-12-01
Letter2017-12-27
Letter2019-07-25
Label2019-07-25
Medication Guide2019-07-25
Letter2019-09-09
Label2019-09-09
Medication Guide2019-09-09
Letter2020-03-03
Label2020-03-04
Label2020-11-09
Medication Guide2020-11-09
Letter2020-11-10
Letter2020-11-10
Label2020-11-12
Letter2021-05-04
Letter2021-05-04
Label2021-05-05
Label2021-05-05
Medication Guide2021-05-05

Application Sponsors

NDA 202992SANOFI AVENTIS US

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL7MG1AUBAGIOTERIFLUNOMIDE
002TABLET;ORAL14MG1AUBAGIOTERIFLUNOMIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP2012-09-12STANDARD
LABELING; LabelingSUPPL2AP2016-11-29STANDARD
LABELING; LabelingSUPPL3AP2016-06-02STANDARD
LABELING; LabelingSUPPL4AP2017-12-19STANDARD
EFFICACY; EfficacySUPPL6AP2019-07-24STANDARD
LABELING; LabelingSUPPL8AP2019-09-06STANDARD
LABELING; LabelingSUPPL10AP2020-02-28STANDARD
LABELING; LabelingSUPPL12AP2020-11-06STANDARD
EFFICACY; EfficacySUPPL13AP2021-04-30STANDARD
LABELING; LabelingSUPPL14AP2020-11-06STANDARD
LABELING; LabelingSUPPL15AP2021-04-30STANDARD

Submissions Property Types

ORIG1Null6
SUPPL2Null33
SUPPL3Null7
SUPPL4Null15
SUPPL6Null15
SUPPL8Null7
SUPPL10Null7
SUPPL12Null7
SUPPL13Null15
SUPPL14Null7
SUPPL15Null7

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

SANOFI AVENTIS US
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202992
            [companyName] => SANOFI AVENTIS US
            [docInserts] => ["Medication Guide","http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/202992s012s014lbl.pdf#page=25"]
            [products] => [{"drugName":"AUBAGIO","activeIngredients":"TERIFLUNOMIDE","strength":"7MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"AUBAGIO","activeIngredients":"TERIFLUNOMIDE","strength":"14MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"Yes"}]
            [labels] => [{"actionDate":"11\/06\/2020","submission":"SUPPL-14","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/202992s012s014lbl.pdf\"}]","notes":""},{"actionDate":"11\/06\/2020","submission":"SUPPL-12","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/202992s012s014lbl.pdf\"}]","notes":""},{"actionDate":"02\/28\/2020","submission":"SUPPL-10","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/202992s010lbl.pdf\"}]","notes":""},{"actionDate":"09\/06\/2019","submission":"SUPPL-8","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/202992s008lbl.pdf\"}]","notes":""},{"actionDate":"09\/06\/2019","submission":"SUPPL-8","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/202992s008lbl.pdf\"}]","notes":""},{"actionDate":"07\/24\/2019","submission":"SUPPL-6","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/202992s006lbl.pdf\"}]","notes":""},{"actionDate":"11\/29\/2016","submission":"SUPPL-2","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/202992s002lbl.pdf\"}]","notes":""},{"actionDate":"11\/29\/2016","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/202992s002lbl.pdf\"}]","notes":""},{"actionDate":"06\/02\/2016","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/202992s003lbl.pdf\"}]","notes":""},{"actionDate":"06\/02\/2016","submission":"SUPPL-3","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/202992s003lbl.pdf\"}]","notes":""},{"actionDate":"10\/17\/2014","submission":"SUPPL-1","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/202992s001lbl.pdf\"}]","notes":""},{"actionDate":"09\/12\/2012","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/202992s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"09\/12\/2012","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 1 - New Molecular Entity","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/202992s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2012\\\/202992Orig1s000ltr.pdf\"},{\"name\":\"Review\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2012\\\/202992Orig1s000TOC.cfm\"},{\"name\":\"Summary Review (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/2012\\\/202992Orig1s000SumR.pdf\"}]","notes":">"}]
            [supplements] => [{"actionDate":"11\/06\/2020","submission":"SUPPL-14","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/202992s012s014lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"\"}]","notes":">"},{"actionDate":"11\/06\/2020","submission":"SUPPL-12","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/202992s012s014lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"\"}]","notes":">"},{"actionDate":"02\/28\/2020","submission":"SUPPL-10","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/202992s010lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/202992Orig1s010ltr.pdf\"}]","notes":">"},{"actionDate":"09\/06\/2019","submission":"SUPPL-8","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/202992s008lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/202992Orig1s008ltr.pdf\"}]","notes":">"},{"actionDate":"07\/24\/2019","submission":"SUPPL-6","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/202992s006lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2019\\\/202992Orig1s006ltr.pdf\"}]","notes":">"},{"actionDate":"12\/19\/2017","submission":"SUPPL-4","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/202992Orig1s004ltr.pdf\"}]","notes":"> Label is not available on this site."},{"actionDate":"06\/02\/2016","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert, Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/202992s003lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/202992Orig1s003ltr.pdf\"}]","notes":">"},{"actionDate":"11\/29\/2016","submission":"SUPPL-2","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/202992s002lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/202992Orig1s002ltr.pdf\"}]","notes":">"},{"actionDate":"10\/17\/2014","submission":"SUPPL-1","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/202992s001lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/202992Orig1s001ltr.pdf\"}]","notes":">"}]
            [actionDate] => 2020-11-06
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.